Incyte
Utility Patent Applications
Last updated:
List of all Incyte patents 26 in total
| Status | Patent |
|---|---|
Application | Utility: RUXOLITINIB FORMULATION FOR REDUCTION OF ITCH IN ATOPIC DERMATITIS Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: SPIROCYCLIC LACTAMS AS JAK2 V617F INHIBITORS Filling date: 6 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS PI3K-y INHIBITORS Filling date: 6 Sep 2025 Issue date: 11 Aug 2022 |
Application | Utility: COMBINATION THERAPY WITH AN ANTI-CD19 ANTIBODY AND PARSACLISIB Filling date: 6 Sep 2025 Issue date: 4 Aug 2022 |
Application | Utility: COMBINATION THERAPY COMPRISING A2A/A2B INHIBITORS, PD-1/PD-L1 INHIBITORS, AND ANTI-CD73 ANTIBODIES Filling date: 6 Sep 2025 Issue date: 28 Jul 2022 |
Application | Utility: COMBINATION THERAPY COMPRISING JAK PATHWAY INHIBITOR AND ROCK INHIBITOR Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: AMINOPYRAZINE DIOL COMPOUNDS AS PI3K-y INHIBITORS Filling date: 6 Sep 2025 Issue date: 7 Jul 2022 |
Application | Utility: JAK INHIBITOR WITH A VITAMIN D ANALOG FOR TREATMENT OF SKIN DISEASES Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: ANTI-CD19 COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 16 Jun 2022 |
Application | Utility: BICYCLIC HETEROARYLAMINOALKYL PHENYL DERIVATIVES AS PI3K INHIBITORS Filling date: 6 Sep 2025 Issue date: 9 Jun 2022 |
Application | Utility: PROCESS FOR MAKING A PD-1/PD-L1 INHIBITOR AND SALTS AND CRYSTALLINE FORMS THEREOF Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: PROCESS OF PREPARING A PD-1/PD-L1 INHIBITOR Filling date: 6 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS Filling date: 6 Sep 2025 Issue date: 5 May 2022 |
Application | Utility: USE OF PYRAZOLOPYRIMIDINE DERIVATIVES FOR THE TREATMENT OF PI3K-DELTA RELATED DISORDERS Filling date: 6 Sep 2025 Issue date: 21 Apr 2022 |
Application | Utility: BICYCLIC DIONE COMPOUNDS AS INHIBITORS OF KRAS Filling date: 6 Sep 2025 Issue date: 7 Apr 2022 |
Application | Utility: HETEROCYCLIC COMPOUNDS AS IMMUNOMODULATORS Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS Filling date: 6 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: PROCESS AND INTERMEDIATES FOR PREPARING A JAK1 INHIBITOR Filling date: 6 Sep 2025 Issue date: 24 Feb 2022 |
Application | Utility: SYSTEMS, METHODS, AND COMPUTER PROGRAMS, FOR ANALYZING IMAGES OF A PORTION OF A PERSON TO DETECT A SEVERITY OF A MEDICAL CONDITION Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: PROCESSES FOR THE PREPARATION OF ARGINASE INHIBITORS AND THEIR SYNTHETIC INTERMEDIATES Filling date: 6 Sep 2025 Issue date: 10 Feb 2022 |
Application | Utility: SUSTAINED RELEASE DOSAGE FORMS FOR A JAK1 INHIBITOR Filling date: 6 Sep 2025 Issue date: 20 Jan 2022 |
Application | Utility: DIHYDROPYRIDO[2,3-D]PYRIMIDINONE COMPOUNDS AS CDK2 INHIBITORS Filling date: 6 Sep 2025 Issue date: 13 Jan 2022 |
Application | Utility: COMBINATION THERAPY COMPRISING AXL/MER AND PD-1/PD-L1 INHIBITORS Filling date: 6 Sep 2025 Issue date: 9 Sep 2021 |
Application | Utility: SPIRO COMPOUNDS AS INHIBITORS OF KRAS Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION THERAPY Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Application | Utility: ANTI-CD73 ANTIBODIES AND USES THEREOF Filling date: 6 Sep 2025 Issue date: 29 Jul 2021 |
Showing 1 to 26 of 26 patents.